994 views4 min read
Psyence Taps Another Pharma Exec to Drive its Clinical Program
TORONTO, May 31, 2022 -- Psyence Group Inc. (CSE: PSYGย |ย OTCQB: PSYGF)ย (โPsyenceโ or the โCompanyโ), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce the appointment of Dr. Clive Ward-Able as the Medical Director of Psyence Group, effective immediately.... Read More...